1. Home
  2. DMLP vs ABCL Comparison

DMLP vs ABCL Comparison

Compare DMLP & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DMLP
  • ABCL
  • Stock Information
  • Founded
  • DMLP 2003
  • ABCL 2012
  • Country
  • DMLP United States
  • ABCL Canada
  • Employees
  • DMLP 27
  • ABCL N/A
  • Industry
  • DMLP Oil & Gas Production
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • DMLP Energy
  • ABCL Health Care
  • Exchange
  • DMLP Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • DMLP 1.2B
  • ABCL 1.1B
  • IPO Year
  • DMLP N/A
  • ABCL 2020
  • Fundamental
  • Price
  • DMLP $25.49
  • ABCL $4.61
  • Analyst Decision
  • DMLP
  • ABCL Strong Buy
  • Analyst Count
  • DMLP 0
  • ABCL 5
  • Target Price
  • DMLP N/A
  • ABCL $8.00
  • AVG Volume (30 Days)
  • DMLP 108.7K
  • ABCL 4.1M
  • Earning Date
  • DMLP 10-30-2025
  • ABCL 11-03-2025
  • Dividend Yield
  • DMLP 12.62%
  • ABCL N/A
  • EPS Growth
  • DMLP N/A
  • ABCL N/A
  • EPS
  • DMLP 1.71
  • ABCL N/A
  • Revenue
  • DMLP $161,859,000.00
  • ABCL $32,875,999.00
  • Revenue This Year
  • DMLP N/A
  • ABCL $15.60
  • Revenue Next Year
  • DMLP N/A
  • ABCL $65.70
  • P/E Ratio
  • DMLP $14.83
  • ABCL N/A
  • Revenue Growth
  • DMLP 4.04
  • ABCL N/A
  • 52 Week Low
  • DMLP $24.01
  • ABCL $1.89
  • 52 Week High
  • DMLP $34.88
  • ABCL $5.82
  • Technical
  • Relative Strength Index (RSI)
  • DMLP 51.88
  • ABCL 59.57
  • Support Level
  • DMLP $24.50
  • ABCL $4.09
  • Resistance Level
  • DMLP $25.60
  • ABCL $4.28
  • Average True Range (ATR)
  • DMLP 0.49
  • ABCL 0.25
  • MACD
  • DMLP 0.16
  • ABCL 0.02
  • Stochastic Oscillator
  • DMLP 90.28
  • ABCL 90.70

About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests

Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: